| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $614,184 ) |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145575 | Development and testing of Carbon Quantum Dot architectures to arrest neurotoxicant-insult- related outcomes | 000 | 3 | NIH | 12/10/2024 | $34,760 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H1740195 | Healthy Tomorrows Partnership for Children Program | 00 | 5 | HRSA | 3/4/2025 | $11,095 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145575 | Development and testing of Carbon Quantum Dot architectures to arrest neurotoxicant-insult- related outcomes | 001 | 3 | NIH | 1/15/2025 | -$4,964 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21CA283583 | A novel gene-based immunotherapy inducing melanoma destruction | 000 | 2 | NIH | 3/3/2025 | $187,453 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA059359 | Sex Differences and The Influence of Ovarian Hormones on the Mechanisms that Promote Nicotine Withdrawal | 001 | 2 | NIH | 12/19/2024 | $43,665 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA059359 | Sex Differences and The Influence of Ovarian Hormones on the Mechanisms that Promote Nicotine Withdrawal | 000 | 2 | NIH | 12/13/2024 | $391,536 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01AI129783 | New chemotherapy regimens and biomarkers for Chagas disease | 000 | 7 | NIH | 12/13/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U1Q53051 | Geriatrics Workforce Enhancement Program | 04 | 1 | HRSA | 12/12/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U1Q53051 | Geriatrics Workforce Enhancement Program | 04 | 1 | HRSA | 12/12/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | P50MD019494 | UTEP Center for Investigator Training and Community Engagement in Transdisciplinary Minority Health Disparities Research | 000 | 1 | NIH | 2/19/2025 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 000 | 3 | NIH | 3/17/2025 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U54CA280922 | UTEP FIRST: United Toward Equity and Progress: Faculty Institutional Recruitment for Sustainable Transformation | 000 | 2 | NIH | 11/20/2024 | $0 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DK132430 | Improving Glycemic Control with Electrical Stimulation in Mexican-Americans | 000 | 2 | NIH | 2/28/2025 | $0 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01CA262788 | Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity | 001 | 2 | NIH | 2/21/2025 | -$1 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R24OD035434 | Advancing Research Operations at an Emergent R1 Minority-Serving Institution | 000 | 1 | NIH | 11/26/2024 | $0 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | SC1GM144171 | Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy | 000 | 2 | NIH | 11/26/2024 | -$6,673 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | TL4GM118971 | Phase II of BUILDing SCHOLARS - Student Training Core | 000 | 10 | NIH | 10/1/2024 | -$5,293 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21CA264627 | The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer | 001 | 2 | NIH | 10/9/2024 | -$1 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01CA262788 | Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity | 000 | 1 | NIH | 2/21/2025 | -$32,008 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | SC1GM132043 | Developing and applying large-scale simulation approach to understand the mechanisms of kinesins' motilities along microtubules | 000 | 4 | NIH | 3/12/2025 | $0 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 2 | NIH | 1/10/2025 | $18,379 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U54MD007592 | Border Biomedical Research Center | 001 | 29 | NIH | 1/22/2025 | $0 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01GM138990 | Structural biology of polyether antibiotic biosynthesis | 000 | 3 | NIH | 12/18/2024 | -$24,009 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DK123079 | Unraveling the Role of NADPH Oxidase in Inflammation-associated Pancreatic Diseases | 002 | 4 | NIH | 1/13/2025 | $46,593 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21CA264627 | The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer | 000 | 1 | NIH | 10/9/2024 | -$46,347 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U54MD007592 | Border Biomedical Research Center | 000 | 28 | NIH | 1/22/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $17,114,285 ) (Continued on the next page) |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21CA283583 | A novel gene-based immunotherapy inducing melanoma destruction | 000 | 1 | NIH | 3/14/2024 | $174,151 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 005 | 3 | NIH | 6/10/2024 | $100,174 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 004 | 3 | NIH | 3/25/2024 | $875,186 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | P50MD019494 | UTEP Center for Investigator Training and Community Engagement in Transdisciplinary Minority Health Disparities Research | 000 | 1 | NIH | 7/13/2024 | $690,085 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA058653 | A2: Striosomal models of drug use and cost | 000 | 1 | NIH | 9/5/2024 | $592,998 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U54CA280922 | UTEP FIRST: United Toward Equity and Progress: Faculty Institutional Recruitment for Sustainable Transformation | 000 | 2 | NIH | 6/19/2024 | $4,984,399 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA059359 | Sex Differences and The Influence of Ovarian Hormones on the Mechanisms that Promote Nicotine Withdrawal | 001 | 1 | NIH | 8/2/2024 | $16,170 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA059359 | Sex Differences and The Influence of Ovarian Hormones on the Mechanisms that Promote Nicotine Withdrawal | 000 | 1 | NIH | 2/29/2024 | $453,040 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21DA059788 | Development of NLRP3 inhibitors for HIV-associated neuroinflammation in cocaine use. | 000 | 1 | NIH | 8/1/2024 | $263,119 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-0001 | EL PASO | USA | R03CA270815 | Development of a Mouse Model to Study Targeted Therapy to Prevent CNS Invasion by Pediatric T-ALL | 000 | 2 | NIH | 11/2/2023 | $76,750 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149379 | Characterization of novel pyrazole compounds with potent anti-cancer activity | 001 | 2 | NIH | 6/18/2024 | $15,136 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149379 | Characterization of novel pyrazole compounds with potent anti-cancer activity | 000 | 2 | NIH | 3/18/2024 | $136,224 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H79SM084281 | The Mental Health Service Provision and Awareness Program ( MHSPAP) | 002 | 2 | SAMHSA | 8/14/2024 | $125,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149426 | The effects of eating a high fat diet on the therapeutic and abuse-related effects of morphine | 001 | 2 | NIH | 7/15/2024 | $15,136 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149426 | The effects of eating a high fat diet on the therapeutic and abuse-related effects of morphine | 000 | 2 | NIH | 3/21/2024 | $136,224 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | T34GM145529 | U-RISE at the University of Texas at El Paso | 000 | 3 | NIH | 3/27/2024 | $786,920 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 4 | NIH | 7/11/2024 | $23,130 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 4 | NIH | 7/11/2024 | $13,667 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 4 | NIH | 7/11/2024 | $8,759 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 000 | 4 | NIH | 3/7/2024 | $331,183 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 000 | 4 | NIH | 3/7/2024 | $78,829 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145559 | SOCS1 is a crucial regulator for uveal melanoma response to immunotherapy | 000 | 3 | NIH | 8/14/2024 | $153,500 |
|
